Video Experimental Relacionado
Updated: Jan 8, 2026
01:27
Pulmonary Embolism III: Nursing Management
Published on: June 19, 2025
320
La expresión génica de la vitelogenina en los hepatocitos machos de Xenopus durante la estimulación primaria y
Cell
|March 1, 1981
Resumen
El estrógeno activa rápidamente la expresión génica de la vitelogenina en las células hepáticas de Xenopus. Este sistema in vitro imita las respuestas in vivo, mostrando activación genética primaria, de retirada y secundaria.
Área de la Ciencia:
- La endocrinología molecular.
- Regulación genética en anfibios.
Sus antecedentes:
- El estrógeno es una hormona clave que regula los procesos reproductivos.
- Vitellogenin es una proteína precursora de la yema de huevo sintetizada en el hígado.
Objetivo del estudio:
- Para investigar la activación del gen de la vitelogenina inducida por estrógeno en cultivos de células hepáticas primarias de Xenopus.
- Establecer un modelo in vitro para el estudio de la expresión génica regulada por hormonas.
Principales métodos:
- Cultivo primario de células parenquimales hepáticas de Xenopus macho.
- Hibridación de discos de papel diazotizados cuantitativos para la detección de ARNm de vitelogenina.
- Análisis del curso temporal a corto y largo plazo de la expresión génica.
- Experimentos de concentración y respuesta de hormonas.
Principales resultados:
- El ARNm de vitelogenina se detectó dentro de las 3 horas de la exposición al estrógeno.
- La acumulación máxima de ARNm se produjo entre las 5-6 horas.
- El sistema in vitro demostró respuesta primaria, abstinencia hormonal y respuesta secundaria mejorada.
- El estradiol indujo una respuesta a 10(-9) M, con el efecto máximo a 10(-6) M.
Conclusiones:
- Las células hepáticas primarias de Xenopus proporcionan un modelo válido para estudiar la expresión génica de la vitelogenina regulada por estrógeno in vitro.
- El sistema in vitro recapitula con precisión los patrones de respuesta hormonal in vivo.
- Se requieren altas concentraciones de estradiol debido al rápido metabolismo celular.
Videos de Conceptos Relacionados
Pulmonary Embolism III: Nursing Management
320
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
320
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
277
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
277
Pulmonary Embolism I: Introduction
464
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
464
Venous Thrombosis III: Interprofessional Care
262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Pneumothorax-II
852
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
852
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K